Nanopharm

Nanopharm, an Aptar Pharma company, is a world-leading specialist contract research organization (CRO) offering product design and development services for orally inhaled and nasal drug products (OINDPs). Operating a fee-for-service model, Nanopharm helps clients navigate the scientific, technical and regulatory challenges of developing nasal and respiratory drug products from discovery through clinical investigations (IND), offering an integrated drug development service covering advanced materials characterization, device and formulation development, and inhaled biopharmaceutics — early-phase services that aid successful product development by understanding how material properties and processing conditions influence product functionality, reducing risk and expediting drug development timelines.